Global Gastroparesis Drugs Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Gastroparesis Drugs Market
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.

Due to the COVID-19 pandemic, the global Gastroparesis Drugs market size is estimated to be worth US$ 5923 million in 2022 and is forecast to a readjusted size of US$ 7625.2 million by 2028 with a CAGR of 4.3% during the review period. Fully considering the economic change by this health crisis, Prokinetic Agents accounting for % of the Gastroparesis Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Diabetic Gastroparesis segment is altered to an % CAGR throughout this forecast period.

North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.

Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Prokinetic Agents

Antiemetic Agents

Others

Segment by Application

Diabetic Gastroparesis

Idiopathic Gastroparesis

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Gastroparesis Drugs market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Sumitomo

Cadila Pharmaceuticals

Sanofi

Teva

Johnson & Johnson

Pfizer

Kyowa Kirin Pharmaceuticals

Hanmi Pharm

Ani Pharmaceuticals

TABLE OF CONTENT

1 Study Coverage
1.1 Gastroparesis Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Gastroparesis Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Prokinetic Agents

1.2.3 Antiemetic Agents

1.2.4 Others

1.3 Market by Application

1.3.1 Global Gastroparesis Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Diabetic Gastroparesis

1.3.3 Idiopathic Gastroparesis

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Gastroparesis Drugs Sales Estimates and Forecasts 2017-2028

2.2 Global Gastroparesis Drugs Revenue Estimates and Forecasts 2017-2028

2.3 Global Gastroparesis Drugs Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Gastroparesis Drugs Sales by Region

2.4.1 Global Gastroparesis Drugs Sales by Region (2017-2022)

2.4.2 Global Sales Gastroparesis Drugs by Region (2023-2028)

2.5 Global Gastroparesis Drugs Revenue by Region

2.5.1 Global Gastroparesis Drugs Revenue by Region (2017-2022)

2.5.2 Global Gastroparesis Drugs Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Gastroparesis Drugs Sales by Manufacturers

3.1.1 Global Top Gastroparesis Drugs Manufacturers by Sales (2017-2022)

3.1.2 Global Gastroparesis Drugs Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gastroparesis Drugs in 2021

3.2 Global Gastroparesis Drugs Revenue by Manufacturers

3.2.1 Global Gastroparesis Drugs Revenue by Manufacturers (2017-2022)

3.2.2 Global Gastroparesis Drugs Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Gastroparesis Drugs Revenue in 2021

3.3 Global Gastroparesis Drugs Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Gastroparesis Drugs Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Gastroparesis Drugs Sales by Type

4.1.1 Global Gastroparesis Drugs Historical Sales by Type (2017-2022)

4.1.2 Global Gastroparesis Drugs Forecasted Sales by Type (2023-2028)

4.1.3 Global Gastroparesis Drugs Sales Market Share by Type (2017-2028)

4.2 Global Gastroparesis Drugs Revenue by Type

4.2.1 Global Gastroparesis Drugs Historical Revenue by Type (2017-2022)

4.2.2 Global Gastroparesis Drugs Forecasted Revenue by Type (2023-2028)

4.2.3 Global Gastroparesis Drugs Revenue Market Share by Type (2017-2028)

4.3 Global Gastroparesis Drugs Price by Type

4.3.1 Global Gastroparesis Drugs Price by Type (2017-2022)

4.3.2 Global Gastroparesis Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Gastroparesis Drugs Sales by Application

5.1.1 Global Gastroparesis Drugs Historical Sales by Application (2017-2022)

5.1.2 Global Gastroparesis Drugs Forecasted Sales by Application (2023-2028)

5.1.3 Global Gastroparesis Drugs Sales Market Share by Application (2017-2028)

5.2 Global Gastroparesis Drugs Revenue by Application

5.2.1 Global Gastroparesis Drugs Historical Revenue by Application (2017-2022)

5.2.2 Global Gastroparesis Drugs Forecasted Revenue by Application (2023-2028)

5.2.3 Global Gastroparesis Drugs Revenue Market Share by Application (2017-2028)

5.3 Global Gastroparesis Drugs Price by Application

5.3.1 Global Gastroparesis Drugs Price by Application (2017-2022)

5.3.2 Global Gastroparesis Drugs Price Forecast by Application (2023-2028)

6 North America

6.1 North America Gastroparesis Drugs Market Size by Type

6.1.1 North America Gastroparesis Drugs Sales by Type (2017-2028)

6.1.2 North America Gastroparesis Drugs Revenue by Type (2017-2028)

6.2 North America Gastroparesis Drugs Market Size by Application

6.2.1 North America Gastroparesis Drugs Sales by Application (2017-2028)

6.2.2 North America Gastroparesis Drugs Revenue by Application (2017-2028)

6.3 North America Gastroparesis Drugs Market Size by Country

6.3.1 North America Gastroparesis Drugs Sales by Country (2017-2028)

6.3.2 North America Gastroparesis Drugs Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Gastroparesis Drugs Market Size by Type

7.1.1 Europe Gastroparesis Drugs Sales by Type (2017-2028)

7.1.2 Europe Gastroparesis Drugs Revenue by Type (2017-2028)

7.2 Europe Gastroparesis Drugs Market Size by Application

7.2.1 Europe Gastroparesis Drugs Sales by Application (2017-2028)

7.2.2 Europe Gastroparesis Drugs Revenue by Application (2017-2028)

7.3 Europe Gastroparesis Drugs Market Size by Country

7.3.1 Europe Gastroparesis Drugs Sales by Country (2017-2028)

7.3.2 Europe Gastroparesis Drugs Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Gastroparesis Drugs Market Size by Type

8.1.1 Asia Pacific Gastroparesis Drugs Sales by Type (2017-2028)

8.1.2 Asia Pacific Gastroparesis Drugs Revenue by Type (2017-2028)

8.2 Asia Pacific Gastroparesis Drugs Market Size by Application

8.2.1 Asia Pacific Gastroparesis Drugs Sales by Application (2017-2028)

8.2.2 Asia Pacific Gastroparesis Drugs Revenue by Application (2017-2028)

8.3 Asia Pacific Gastroparesis Drugs Market Size by Region

8.3.1 Asia Pacific Gastroparesis Drugs Sales by Region (2017-2028)

8.3.2 Asia Pacific Gastroparesis Drugs Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Gastroparesis Drugs Market Size by Type

9.1.1 Latin America Gastroparesis Drugs Sales by Type (2017-2028)

9.1.2 Latin America Gastroparesis Drugs Revenue by Type (2017-2028)

9.2 Latin America Gastroparesis Drugs Market Size by Application

9.2.1 Latin America Gastroparesis Drugs Sales by Application (2017-2028)

9.2.2 Latin America Gastroparesis Drugs Revenue by Application (2017-2028)

9.3 Latin America Gastroparesis Drugs Market Size by Country

9.3.1 Latin America Gastroparesis Drugs Sales by Country (2017-2028)

9.3.2 Latin America Gastroparesis Drugs Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Gastroparesis Drugs Market Size by Type

10.1.1 Middle East and Africa Gastroparesis Drugs Sales by Type (2017-2028)

10.1.2 Middle East and Africa Gastroparesis Drugs Revenue by Type (2017-2028)

10.2 Middle East and Africa Gastroparesis Drugs Market Size by Application

10.2.1 Middle East and Africa Gastroparesis Drugs Sales by Application (2017-2028)

10.2.2 Middle East and Africa Gastroparesis Drugs Revenue by Application (2017-2028)

10.3 Middle East and Africa Gastroparesis Drugs Market Size by Country

10.3.1 Middle East and Africa Gastroparesis Drugs Sales by Country (2017-2028)

10.3.2 Middle East and Africa Gastroparesis Drugs Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Sumitomo

11.1.1 Sumitomo Corporation Information

11.1.2 Sumitomo Overview

11.1.3 Sumitomo Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Sumitomo Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Sumitomo Recent Developments

11.2 Cadila Pharmaceuticals

11.2.1 Cadila Pharmaceuticals Corporation Information

11.2.2 Cadila Pharmaceuticals Overview

11.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Cadila Pharmaceuticals Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Cadila Pharmaceuticals Recent Developments

11.3 Sanofi

11.3.1 Sanofi Corporation Information

11.3.2 Sanofi Overview

11.3.3 Sanofi Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Sanofi Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Sanofi Recent Developments

11.4 Teva

11.4.1 Teva Corporation Information

11.4.2 Teva Overview

11.4.3 Teva Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Teva Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Teva Recent Developments

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Corporation Information

11.5.2 Johnson & Johnson Overview

11.5.3 Johnson & Johnson Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Johnson & Johnson Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Johnson & Johnson Recent Developments

11.6 Pfizer

11.6.1 Pfizer Corporation Information

11.6.2 Pfizer Overview

11.6.3 Pfizer Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Pfizer Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Pfizer Recent Developments

11.7 Kyowa Kirin Pharmaceuticals

11.7.1 Kyowa Kirin Pharmaceuticals Corporation Information

11.7.2 Kyowa Kirin Pharmaceuticals Overview

11.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Kyowa Kirin Pharmaceuticals Recent Developments

11.8 Hanmi Pharm

11.8.1 Hanmi Pharm Corporation Information

11.8.2 Hanmi Pharm Overview

11.8.3 Hanmi Pharm Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Hanmi Pharm Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Hanmi Pharm Recent Developments

11.9 Ani Pharmaceuticals

11.9.1 Ani Pharmaceuticals Corporation Information

11.9.2 Ani Pharmaceuticals Overview

11.9.3 Ani Pharmaceuticals Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Ani Pharmaceuticals Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Ani Pharmaceuticals Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Gastroparesis Drugs Industry Chain Analysis

12.2 Gastroparesis Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Gastroparesis Drugs Production Mode & Process

12.4 Gastroparesis Drugs Sales and Marketing

12.4.1 Gastroparesis Drugs Sales Channels

12.4.2 Gastroparesis Drugs Distributors

12.5 Gastroparesis Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Gastroparesis Drugs Industry Trends

13.2 Gastroparesis Drugs Market Drivers

13.3 Gastroparesis Drugs Market Challenges

13.4 Gastroparesis Drugs Market Restraints

14 Key Findings in The Global Gastroparesis Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample